Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Anti-EphA2 monoclonal antibody conjugated to maleimidocaproyl monomethylauristatin phenylalanine

EU orphan designation number: EU/3/09/682
Active ingredient: Anti-EphA2 monoclonal antibody conjugated to maleimidocaproyl monomethylauristatin phenylalanine
Indication: Treatment of ovarian cancer
Sponsor: MedImmune Ltd
Milstein Building, Granta Park, Great Abington, Cambridgeshire, CB21 6GH, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/10/2009 Centralised Orphan - Designation EMEA/OD/071/09 (2009)8520 of 28/10/2009
09/11/2010 Centralised Orphan - Removal of orphan designation from Community Register